RxDoctor Payments Data

Mark Wasserman

Obstetrics & Gynecology · Sullivan, MONPI 1225130933

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 31.5% of the total. Reporting peaked in 2021 at $407 and has fallen 91.6% since, to $34 in 2024.

$942in general payments, 2019–2025

Across 62 payments — averaging $15.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$297
  • Mylan Pharmaceuticals Inc.$60
  • Covidien LP$60
  • Agile Therapeutics, Inc.$58
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$52
  • GSK$51
  • plus $364 from 16 others

What the payments were for

  • Food & beverage$92698%
  • Education$152%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$942 in reported general payments places this provider in the 60th percentile of 750 obstetrics & gynecology providers in Missouri.

See all obstetrics & gynecology providers in Missouri →

Other obstetrics & gynecology in Sullivan

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →